modified oligonucleotide therapy (Triplet Therapeutics)

N/A

Report date: 2025/03/20 16:07:47
NME

Base Information

Drug Namemodified oligonucleotide therapy (Triplet Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTriplet Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTriplet Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A